When evaluating the therapeutic response for a client receiving a heparin infusion, which laboratory results should the nurse monitor?

1. A

   Complete blood count (CBC)

2. B

   Activated partial thromboplastin time (aPTT)

3. C

   International normalized ratio (INR)

4. D

   Prothrombin time (PT)

Appeared in: NORCET 5 mains

Explanation

Listen in Hindi

• Activated partial thromboplastin time (aPTT) is the standard laboratory test used to monitor the therapeutic efficacy of unfractionated heparin infusions.
• Heparin primarily affects the intrinsic coagulation pathway, and the aPTT test specifically measures the speed of clotting through this pathway.
• The therapeutic goal is to prolong the aPTT to 1.5 to 2.5 times the patient's baseline or the control value, ensuring a balance between preventing thrombosis and avoiding hemorrhage.
• Regular monitoring allows for timely dose adjustments of the heparin infusion to maintain the aPTT within the desired therapeutic window.

Why Other Options Were Wrong

• Option A: A Complete Blood Count (CBC) does not measure the anticoagulant effect of heparin. It assesses overall blood health, including red cells, white cells, and platelets.
• Option C: The International Normalized Ratio (INR) is the standardized test for monitoring the effectiveness of the oral anticoagulant warfarin (Coumadin), not heparin.
• Option D: Prothrombin Time (PT) measures the extrinsic coagulation pathway and is used to monitor warfarin therapy, not heparin.

Related Visual

• Visual 1: Table - Comparison of Coagulation Tests: A table clearly differentiating aPTT, PT/INR, and CBC, showing which drug each test monitors and its purpose (therapeutic effect vs. side effect monitoring).

Clinical Relevance

• Nursing practice connection: Use the key finding related to Laboratory Monitoring of Anticoagulant Therapy to guide bedside assessment, documentation, and the next nursing action.
• Nurses are responsible for ensuring aPTT levels are drawn at the correct intervals (e.g., 6 hours after initiation or a dose change) and for adjusting heparin infusion rates based on hospital-specific protocols to keep the aPTT in the therapeutic range.
• A subtherapeutic aPTT places the client at risk for clotting, while a supratherapeutic (excessively high) aPTT increases the risk of life-threatening hemorrhage. Promptly reporting critical values to the provider is a key patient safety intervention.
• What if the client was on Low-Molecular-Weight Heparin (LMWH) like enoxaparin? In that case, routine aPTT monitoring is generally not required because LMWH has a more predictable dose-response. Monitoring is reserved for specific populations like those with renal failure or obesity.

How to Approach the Question

• First, identify the key medication in the question stem, which is 'heparin infusion'.
• Next, recall the specific laboratory test used to measure the therapeutic effect of this particular medication.
• Differentiate between tests that measure therapeutic effect versus those that monitor for side effects. The question asks for 'therapeutic response'.
• Eliminate options associated with other anticoagulant medications. For example, recognize that PT/INR is used for warfarin.
• Select the option that directly correlates with monitoring the anticoagulant activity of heparin.

Concept Tested & Keywords

• Concept Tested: Laboratory Monitoring of Anticoagulant Therapy
• Stem keywords: heparin infusion, therapeutic response, laboratory results, monitor
• Lead-in keywords: which
• Negative lead-in flag: false

Question ID

Q8zVlEbs6szW-LLgzP9w90

Copy ID